24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Conditions Treated Asbestosis Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Pleural Mesothelioma
Hospitals & Clinics
specialties & services
Dr. Jan Buckner is a medical oncologist in Rochester, Minnesota. He got his medical degree from University of North Carolina at Chapel Hill School of Medicine and did his residency at Spectrum Health-Butterworth Campus. Dr. Buckner went to Mayo School of Graduate Medical Education and obtained his fellowship in medical oncology. He is certified by the American board in both medical oncology and internal medicine. Dr. Buckner has over 20 years of experience and is currently affiliated with Mayo Clinic – Rochester.
Aetna Choice POS IICareFirst BCBSCignaFirst Health PPOHumanaMultiPlanUnited Healthcare
University of North Carolina at Chapel Hill School of Medicine
Medical School
Spectrum Health-Butterworth Campus
Residency
Mayo School of Graduate Medical Education
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Mayo Clinic Rochester
Languages: English/Spanish
507-284-2511
200 S. W. First Street
Rochester, Minnesota 55905 
MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
Korfiatis, P.,Kline, T. L.,Coufalova, L.,Lachance, D. H.,Parney, I. F.,Carter, R. E.,Buckner, J. C.,Erickson, B. J.; Med Phys.
See more >>
Pragmatic study designs for older adults with cancer: Report from the U13 conference.
Nipp, R. D.,Yao, N. A.,Lowenstein, L. M.,Buckner, J. C.,Parker, I. R.,Gajra, A.,Morrison, V. A.,Dale, W.,Ballman, K. V.; J Geriatr Oncol.
See more >>
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).
Brown, P. D.,Anderson, S. K.,Carrero, X. W.,O\'Neill, B. P.,Giannini, C.,Galanis, E.,Shah, S. A.,Abrams, R. A.
See more >>
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
Berg, A. K.,Buckner, J. C.,Galanis, E.,Jaeckle, K. A.,Ames, M. M.,Reid, J. M.; J Clin Pharmacol
See more >>
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma:
NCCTG N057K. Ma, D. J.,Galanis, E.,Anderson, S. K.,Schiff, D.,Kaufmann, T. J.,Peller, P. J.,Giannini, C.,Brown, P. D.,Uhm, J. H.,McGraw, S.,Jaeck
See more >>Memberships
American Society of Clinical Oncology